Airbus in advanced talks for $10 billion easyJet order: sources
By Rhys Jones and Tim Hepher LONDON/PARIS (Reuters) - Airbus is in advanced talks to complete a $10 billion order for at least 100 ...
Read More »Business News
Subscribe to the Business News feed.-
-
SEC says Revlon misled shareholders in a Perelman deal
By Jonathan Stempel (Reuters) - The Securities and Exchange Commission charged Revlon Inc with misleading shareholders about a trans...
Read More » -
Coty fails to charm investors in market debut
By Ashutosh Pandey (Reuters) - Shares of perfume and beauty products seller Coty Inc fell more than 3 percent in their market debut...
Read More » -
Bernanke to deliver semi-annual testimony to Congress July 17-18
WASHINGTON (Reuters) - Federal Reserve Chairman Ben Bernanke will deliver his semi-annual testimony to the U.S. Congress on July 17 ...
Read More » -
Southwest Air sees key revenue measure weakening in second quarter
(Reuters) - Southwest Airlines Co said it expects an important revenue measure to decline in the second quarter, saying it is havin...
Read More » -
DuPont says wet spring to hit operating profit
(Reuters) - Chemical maker DuPont said its operating profit would fall more than it expected in the first half of the year as a wet...
Read More » -
EU files WTO complaint over Chinese stainless steel duty
By Tom Miles GENEVA (Reuters) - The European Union lodged a complaint at the World Trade Organization on Thursday against China's im...
Read More » -
Marathon Oil CEO to retire December 31, be replaced by Exxon executive
(Reuters) - Marathon Oil Corp said on Thursday that Chairman and Chief Executive Clarence Cazalot will retire December 31 and be re...
Read More » -
Sales, jobs data show underlying economic strength
By Lucia Mutikani WASHINGTON (Reuters) - Retail sales rose more than expected in May and first-time applications for unemployment be...
Read More » -
Irish drug firm Elan puts itself up for sale
DUBLIN (Reuters) - Irish drug company Elan put itself up for sale on Friday, seeking to fend off a hostile bid by Royalty Pharma t...
Read More »